Exploration of cyclooxygenase-1 binding modes of some chiral anti-inflammatory drugs using molecular docking and dynamic simulations
by Meriem Meyar; Samira Feddal; Zohra Bouakouk; Safia Kellou-Tairi
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 12, No. 3, 2019

Abstract: The profens represent an important class of chiral anti-inflammatory drugs. They are often marketed as racemic mixtures, but one of their enantiomers R or S can be inactive or toxic. With the aim of evaluating the anti-inflammatory activity of each enantiomer, it would be useful to first theoretically predict the enantiomer responsible for this activity. For that, three well known profens: ibuprofen, flurbiprofen, naproxen and some of their derivatives have been selected from the literature and were studied through docking and molecular dynamic (MD) simulations. Analysis of the recognition modes, through interactions with relevant residues of the cyclooxygenase-1(COX-1), can predict and explain which enantiomer is the most active. MD study highlights that water molecules play an important role in ligand-receptor interactions. Also, our combined study showed the preference of the profen's S-enantiomer towards the COX-1 active site in contrast to R-enantiomer.

Online publication date: Tue, 23-Jul-2019

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com